Siemens Healthineers sponsors the Annual Scientific Activities of Central Public Health Laboratories (CPHL) event for the second consecutive year
The One Health Approach 2020 event focuses on sharing knowledge, technical skills and scientific experience in the healthcare field with a focus on infectious diseases
Siemens Healthineers provides support to healthcare providers at each stage of COVID-19 patient care: diagnosis, prognosis, therapy and follow-up
Cairo, Egypt, 11th November 2020
Siemens Healthineers, a leader in healthcare imaging and diagnostic technology, is participating as a platinum sponsor for the 2nd Annual Scientific Activities of Central Public Health Laboratories (CPHL) taking place November 10 – 12, 2020 at the Central Public Health Laboratories (MoH), Cairo, Egypt.
Under the theme "One Health Approach 2020," the first day of the seminar was inagurated yestarday by her Excellency Dr. Hala Zayed, Mininster of Health and Population; and Dr. Nancy El-Guindy, Director of Egypt's Central Public Health Laboratories (CPHL) followed by scientific lectures at the MoH’s National Training Institution (NTI) that focused on infectious diseases with the global COVID-19 pandemic, laboratory diagnosis and LCD array classification of Mycobacteria (TB complex & other than TB MOTT). The second and third days will include workshops at spcialized labs in the Central Public Health laboratories.
”Siemens Healthineers enables healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare,“ said Michael Schmermer, Managing Director - Egypt, Djibouti, Eretria, Sudan, and Libya, Siemens Healthcare S.A.E. “Our partipication in this notable industry conference allows us the unique opportuinity to connect with some of the brightest minds in the healthcare field today, who truely believe, as we do, that innovation shapes the future of healthcare.”
The event is organized by the Central Public Health Laboratories in accordance with strict safety measures and social distancing following all COVID-19 global protocoles. This year, the scientific workshop will focus on the infectious diseases with the global COVID-19 pandemic, laboratory diagnosis and LCD array classification of Mycobacteria (TB complex & other than TB MOTT).
Siemens Healthineers provides support to healthcare providers at each stage of COVID-19 patient care: diagnosis, prognosis, therapy and follow-up. The company‘s laboratory diagnostics and point of-care testing solutions can help physicians make a prognosis about the severity of a COVID-19 case, help treat the patient, and assist in the follow-up to find out when the patient has recovered.
The company‘s COVID-19 response covers the detection of either antigen or Antibody of SARS-CoV2 virus through diversified products including:
New FTD Real Time PCR assay with a dual target design for SARS-CoV 2 identification provides assay robustness and optimal sensitivity, specificity and inclusivity to be used as a confirmatory not screening test.
The CLINITEST Rapid COVID-19 antigen test is a point of care cassette test that does not require Lab instrument or specialist lab personal to administer, and it delivers results within 15 minutes.
For SARS-COV2 Antibody testing, Siemens Healthineers offers both the SARS-CoV-2 Total Antibody test and the SARS-CoV-2 IgG Antibody test. The combination of these tests provides a complete picture of a patient’s serological status for the most accurate results throughout his or her continuum of care. The company provides this type of testing on several types of Lab instruments in addition to POC Rapid test cassettes.
Siemens Healthineers is a leading medical technology company with over 120 years of experience and 18,500 patents globally. With over 50,000 employees in more than 70 countries, an estimated five million patients worldwide everyday benefit from the company’s innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services.